October 6, 2025
Headlines

New EASO guidance recommends semaglutide and tirzepatide as first-line treatments for obesity and its major complications.

DRRA01 mins
New EASO guidance recommends semaglutide and tirzepatide as first-line treatments for obesity and its major complications.


New EASO guidance recommends semaglutide and tirzepatide as first-line treatments for obesity and its major complications.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Related News